您的位置: 首页 > 农业专利 > 详情页

Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
专利权人:
Ltd.;Alcon Research
发明人:
Kabra, Bhagwati P.
申请号:
AU2010221438
公开号:
AU2010221438B2
申请日:
2010.03.03
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
Disclosed are efficacious pharmaceutical compositions in the form of intraocular suspensions comprising an anti-angiogenic compound in a therapeutically effective amount and a polyethylene glycol having a molecular weight of at least 2000, preferably at least 3000. The compositions are preferably for treatment of ocular disorders, such as diabetic retinopathy, age-related macular degeneration, macular edema, uveitis, and geographic atrophy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充